Clinical Trial Update: Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing safety of anidulafungin versus amphotericin B in high-risk liver transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infection
• Liver Disease

Drugs mentioned

• Amphotericin B (Amphotericin B)
• Anidulafungin (Eraxis) (anidulafungin)

Snippet

Sponsor: Fundacion SEIMC-GESIDA | Conditions: Liver Disease, Fungal Infection | Phase 4 | Status: COMPLETED